4th Apr 2011 14:45
RNS Number : 2579E
AGI Therapeutics plc
04 April 2011
AGI Therapeutics plc ('AGI')
Holding in Company
AGI was notified on 4 April 2011 that Irish Life Investment Managers had decreased its shareholding to 2,474,049 Ordinary Shares representing 3.67% of AGI's Issued Share Capital.
Contact Information
AGI Therapeutics
David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Potentially Ai